Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk

American Journal of Preventive Cardiology(2022)10.1016/j.ajpc.2022.100450Source: DataRank Database

Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk is a research paper published in American Journal of Preventive Cardiology (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.43)OA: goldTopics (17)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Mingyuan Zhang ORCID,Molly B. Conroy ORCID,Alexander R. Zheutlin ORCID

Live enrichment

PubMed:36593972 PMC:PMC9804006 OpenAlex:https://openalex.org/W4311969897

NHLBI NIH HHS

Grant: R38 HL143605

National Institutes of Health

Grant: 5R38HL143605-02

Utah Stimulating Access to Research in Residency Transition Scholar (StARRTS)

National Institutes of Health

FWCI

0.43

Citation Percentile

0.6%

Citation Trend

2023

2024

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.ajpc.2022.100450

publisherhttps://doi.org/10.1016/j.ajpc.2022.100450

publisherhttps://api.elsevier.com/content/article/PII:S2666667722001349?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666667722001349?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36593972

Fields of Study

Lipoproteins and Cardiovascular HealthHealth Systems, Economic Evaluations, Quality of LifeDiabetes, Cardiovascular Risks, and Lipoproteins03 medical and health sciences0302 clinical medicine

Keywords

MedicinePrimary preventionAtherosclerotic cardiovascular diseaseDiseaseStatinInternal medicineCardiologyOriginal Research ContributionRC666-701Diseases of the circulatory (Cardiovascular) systemPublic aspects of medicineRA1-1270

Sustainable Development Goals

SDG 0: Good health and well-being